CaReSyAn

  This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 764474.  

Title

Combatting the CardioRenal Syndrome: towards an integrative Analysis reduce cardiovascular burden in chronic kidney disease

Concept

Successfully combatting a complex disease requires multi-disciplinary and methodically well-trained scientists. CaReSyAn strives to accomplish exactly this: we will train scientists to successfully integrate proteomics, clinical, experimental and bioinformatical analyses to enhance the understanding, diagnosis and therapy of the cardiorenal syndrome (CRS). CRS comprises disorders of the heart, vessels and kidneys, including the increased development of cardiovascular disease (CVD) in patients with chronic kidney disease (CKD). With approx. 45 percent of all deaths in CKD patients caused by CVD, the socio-economic burden of CRS is extremely high.

Participants

• Idryma Iatroviologikon Erevnon Tis Akadimas S.A., Greece
• Mosaiques Diagnostics GmbH, Germany
• Medizinische Universität Wien, Austria
• RD-Néphrologie SAS, France
• Institut national de la santé et de la recherche médicale, France
• Universteit Maastricht, Netherlands
• Karolinska Institutet, Sweden
• DSM Materials Science Center B.V., Netherlands
• DSM R&D Solutions, Netherlands